Shandong Weigao buys back H-shares, boosts treasury holdings

Shandong Weigao Group Medical Polymer Company Limited repurchased 607,600 H-shares on December 11, 2025, at an aggregate price of HK$3,169,232. The repurchase price per share ranged from HK$5.17 to HK$5.28, with a volume-weighted average price of HK$5.216. This transaction increased the company's treasury shares from 29,309,200 to 29,916,800.

The buyback represents a 0.0135% change relative to the existing number of issued shares (excluding treasury shares) prior to the event. Following the repurchase, the total number of issued shares remained unchanged at 4,522,332,324, while issued shares excluding treasury shares decreased from 4,493,023,124 to 4,492,415,524.

The repurchase was conducted on the Exchange under a mandate granted on May 27, 2025, which authorized the company to repurchase up to 451,560,392 shares. To date, 23,268,400 shares have been repurchased under this mandate, representing 5.1529% of the issued shares (excluding treasury shares) as of the resolution date. A moratorium period for new share issues or treasury share sales is in effect until January 10, 2026.